Novanta Announces Financial Results for the Third Quarter 2026
Business Wire•09/11/2026•16:45 ET
0
Key Highlights
- ➤Q3 revenue $305 million, up 23.1% year-over-year
- ➤Adjusted EBITDA $80.3 million, up 38.3% year-over-year
- ➤Adjusted diluted EPS $1.05, up 20.7% year-over-year
- ➤Q4 revenue guidance $306 million to $312 million; adjusted EPS $0.91 to $0.96
- ➤Full-year revenue guidance $1,135 million to $1,140 million; adjusted EBITDA $274 million to $277 million
Expert Statements
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“The third quarter marked a significant milestone for Novanta as we closed the largest acquisition in our history and delivered strong financial results that exceeded our expectations.”
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“Momentum continued in the third quarter as revenue advanced 23% and we achieved an Adjusted EBITDA margin of 26%, which improved 290 basis points year-over-year.”
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“Customer bookings increased 29%, reflecting strong commercial momentum and providing a solid foundation for future growth, expanding our backlog to $543 million.”
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“Equally important, Riverpoint Medical is performing in line with expectations as we continue to make meaningful progress on our operational synergies, while driving an exciting new product pipeline.”
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“Collectively, these results demonstrate the strength of our strategy and our continued commitment to driving sustainable growth and long-term shareholder value.”
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“With strong year-to-date performance and continued momentum in customer bookings, we remain on track to deliver on our full year outlook of approximately 7% Organic Revenue Growth, (or 16% on a reported basis), more than 24% growth in Adjusted EBITDA, and approximately $200 million in operating cash flow.”
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“Our strong backlog, new product contributions and leading positions in markets benefiting from favorable long-term secular trends provide a solid foundation for future growth and value creation.”
Matthijs Glastra, Chair and Chief Executive Officer of Novanta
“Looking ahead to 2027, we expect reported revenue growth of more than 15%.”
Novanta Announces Financial Results for the Third Quarter 2026
Third Quarter 2026 GAAP Revenue increased 23% to $305 million
Get started
Create a free account to read the full story.